NCT04389632 2026-04-20A Study of Sigvotatug Vedotin in Advanced Solid TumorsSeagen Inc.Phase 1 Recruiting1,006 enrolled
NCT07217171 2026-04-13A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell CarcinomasEvolveImmune United, IncPhase 1 Recruiting160 enrolled
NCT07090499 2026-04-07A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsPfizerPhase 1 Recruiting310 enrolled
NCT07277413 2026-04-03A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsIDEAYA BiosciencesPhase 1 Recruiting260 enrolled
NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT06242470 2026-02-05A Study of MGC026 in Participants With Advanced Solid TumorsMacroGenicsPhase 1 Recruiting250 enrolled
NCT06781983 2026-01-07Safety and Tolerability of IPH4502 in Patients With Advanced Solid TumorsInnate PharmaPhase 1 Recruiting145 enrolled
NCT06265285 2025-12-04Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramMayo ClinicPhase 2 Recruiting50 enrolled
NCT05914116 2025-11-21A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsDualityBio Inc.Phase 1/2 Recruiting862 enrolled
NCT04510129 2025-03-12A Multicenter Cancer Biospecimen Collection StudyCofactor Genomics, Inc.Recruiting1,650 enrolled